ABC-10 (SAFIR ABC-10 Precision Medicine)
SAFIR ABC-10 Precision Medicine - Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open- label, platform phase 3 trial
This is a Phase 3, multicentre, randomised, open-label trial to evaluate whether the introduction of molecular targeted therapy (MTT) as maintenance after 4 cycles of standard-of-care first-line syste [...]
Area:
Upper gastro-intestinal cancer
Phase:
Phase III
Status:
Active (recruiting)